TRAITEMENT DE MALADIES ASSOCIÉES À UN GÈNE DE DÉVELOPPEMENT PANCRÉATIQUE PAR INHIBITION DU PRODUIT DE LA TRANSCRIPTION ANTI-SENS NATUREL EN UN GÈNE DE DÉVELOPPEMENT PANCRÉATIQUE
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Pancreatic Developmental gene, in particular, by targeting natural antisense polynucleotides of a Pancreatic Developmental gene. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Pancreatic Developmental genes.
